+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Cystic Fibrosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767558
  • Report
  • April 2019
  • Region: Global
  • 484 pages
  • VPA Research

FEATURED COMPANIES

  • Allergan Plc
  • F. Hoffmann-La Roche Ltd
  • Galapagos NV
  • Gilead Sciences Inc
  • Merck & Co Inc
  • Nivalis Therapeutics Inc
The global clinical trial report- “2019 Cystic Fibrosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Cystic Fibrosis. It presents in-depth analysis of Cystic Fibrosis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Cystic Fibrosis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Cystic Fibrosis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Cystic Fibrosis

The research work is prepared through extensive and continuous research on Cystic Fibrosis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Cystic Fibrosis patients are identified
  • The report includes panorama of Cystic Fibrosis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Cystic Fibrosis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan Plc
  • F. Hoffmann-La Roche Ltd
  • Galapagos NV
  • Gilead Sciences Inc
  • Merck & Co Inc
  • Nivalis Therapeutics Inc
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Cystic Fibrosis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Cystic Fibrosis Clinical Trials by Region
2.2.2 Average Enrollment of Cystic Fibrosis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Cystic Fibrosis Treatment, 2019

3. Region wise Cystic Fibrosis Clinical Trials
3.1 Asia Pacific Cystic Fibrosis Clinical Trials by Country
3.2 Europe Cystic Fibrosis Clinical Trials by Country
3.3 North America Cystic Fibrosis Clinical Trials by Country
3.4 Middle East and Africa Cystic Fibrosis Clinical Trials by Country
3.5 South and Central America Cystic Fibrosis Clinical Trials by Country

4. Cystic Fibrosis Clinical Trial Trends
4.1 Start Year wise Cystic Fibrosis Clinical Trials
4.2 Phase wise Cystic Fibrosis Clinical Trials
4.3 Trial Status wise Cystic Fibrosis Clinical Trials
4.4 Trial Type wise Cystic Fibrosis Clinical Trials

5. Cystic Fibrosis Average Enrollment Trends
5.1 Average Enrollment in Cystic Fibrosis Trials by Year
5.2 Average Enrollment in Cystic Fibrosis Trials by Phase
5.3 Average Enrollment in Cystic Fibrosis Trials by Status
5.4 Average Enrollment in Cystic Fibrosis Trials by Type of Trial

6. Companies Participating in Cystic Fibrosis Clinical Trials
6.1 Cystic Fibrosis Trials by Sponsor Type
6.2 Cystic Fibrosis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Cystic Fibrosis Trials- Phase 1
7.2 Cystic Fibrosis Trials- Phase 2
7.3 Cystic Fibrosis Trials- Phase 3
7.4 Cystic Fibrosis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Cystic Fibrosis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Cystic Fibrosis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Cystic Fibrosis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Cystic Fibrosis Clinical Trials and Enrolment
Figure 7: North America - Country wise Cystic Fibrosis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Cystic Fibrosis Clinical Trials and Enrolment
Figure 9: Cystic Fibrosis Clinical Trials by Phase
Figure 10: Cystic Fibrosis Clinical Trials by Trial Status
Figure 11: Cystic Fibrosis Clinical Trials by Type
Figure 12: Cystic Fibrosis Clinical Trials by Sponsor Type
Figure 13: Cystic Fibrosis Clinical Trials by Leading Sponsors
Figure 14: Cystic Fibrosis Average Enrollment by Phase
Figure 15: Cystic Fibrosis Average Enrollment by Trial Status
Figure 16: Cystic Fibrosis Average Enrollment by Type
Figure 17: Cystic Fibrosis- Average Enrolment by Type of Sponsors
Figure 18: Cystic Fibrosis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Cystic Fibrosis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Cystic Fibrosis Clinical Trials and Enrolment
Table 5: Europe - Country wise Cystic Fibrosis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Cystic Fibrosis Clinical Trials and Enrolment
Table 7: North America - Country wise Cystic Fibrosis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Cystic Fibrosis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Cystic Fibrosis Average Enrollment by Phase
Table 15: Cystic Fibrosis Average Enrollment by Trial Status
Table 16: Cystic Fibrosis Average Enrollment by Type
Table 17: Cystic Fibrosis- Average Enrolment by Type of Sponsors
Table 18: Cystic Fibrosis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
  • Allergan Plc
  • C. H. Boehringer Sohn AG & Co KG
  • Cystic Fibrosis Foundation
  • F. Hoffmann-La Roche Ltd
  • Galapagos NV
  • Gilead Sciences Inc
  • Merck & Co Inc
  • Nivalis Therapeutics Inc
  • Novartis AG
  • Vertex Pharmaceuticals Inc
Note: Product cover images may vary from those shown
Adroll
adroll